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WHAT THIS PAPER ADDS
 No ofﬁcial maximum surgical blood order schedule (MSBOS) exists for elective Endovascular Aneurysm Repairs (EVARs). Most
centres crossmatch two units of blood but there have been no published data on this topic. We review the crossmatching trends of
our growing elective EVAR workload and have highlighted an inefﬁcient crossmatching process and ﬁnancial loss associated with
wastage of red blood cell units in our trust. We conclude that an MSBOS policy of a group and save serum alone is appropriate.
However an efﬁcient emergency transfusion protocol is necessary for the rare (<1%) cases of intraoperative massive haemorrhage.a r t i c l e i n f o
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Objectives: The unit cost for crossmatching blood is £137.22 (V158.94). A maximum surgical blood order
schedule for elective EVAR does not exist. We studied the crossmatch to transfusion ratio in our series to
establish this recommendation.
Materials and methods: A single centre retrospective study of consecutive EVAR cases between October
2001 and December 2010. Blood loss, units transfused and indication for transfusion per case were
analysed.
Results: 203 elective EVAR cases were studied. Median blood loss was 200 ml with a mean of 288 ml
(range 50e8400 ml). A total of twelve patients (6%) required blood transfusion. Six cases (3%) for
postoperative Hb <8 g/dL and three patients (1.5%) for medical complications. Three patients required
a massive transfusion; two had peri-procedural haemorrhage and one patient developed a large groin
haematoma. The crossmatch to transfusion ratio was 11.1.
Conclusions: The maximum surgical blood order for elective EVAR should be a group and save (type and
screen) sample because of the high crossmatch to transfusion ratio. Intraoperative transfusion is rarely
required (<1%) but often necessitates large transfusion quantities. In this circumstance each hospital is
required to have an emergency protocol to manage massive blood loss. Applying these principles across
all surgical specialities may lead to signiﬁcant ﬁnancial savings, improve efﬁciency and reduce wastage.
Crown Copyright  2011 Published by Elsevier Ltd on behalf of European Society for Vascular Surgery. All
rights reserved.Introduction
Endovascular aneurysm repair (EVAR) has become the ﬁrst line
treatment for abdominal aorta aneurysm (AAA) throughout the
United Kingdom. It is the policy of the majority of vascular units to
crossmatch four to six units of red blood cells for open AAA repair
but recommendations do not exist for EVAR.tions on this paper, please go
011 Published by Elsevier Ltd onMean reported blood loss during elective EVAR ranges from
200 ml to 500 ml.1e3 Blood loss in EVAR most commonly occurs
from multiple guidewire and sheath exchanges and peri-sheath
leakage at the iliac arteries. Major complication rates are low but
iatrogenic intraoperative rupture often requires massive trans-
fusion which inﬂuences local routine crossmatching policy for all
procedures.1e3 Overall transfusion rates are reported to be between
4.2% and 25% and peroperative transfusion rates 13%e18%.4e7 There
is clear documented evidence that elective EVAR has markedly
reduced blood loss and transfusion rates, compared to open
repair.2,8 Hospital transfusion services have attempted to reduce
the quantities of crossmatched blood made available for operative
procedures. The reasons for this are: to reduce over crossmatchingbehalf of European Society for Vascular Surgery. All rights reserved.
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of the transfusion department personnel, to reduce the potential
risk of harm from transfusion and to reduce the signiﬁcant and
rising ﬁnancial costs of crossmatching blood.9,10 The Maximum
Surgical Blood Order Schedule (MSBOS) refers to a list of proce-
dures with a recommended quantity of red blood cell units to be
crossmatched preoperatively. It is based upon a retrospective
review of blood usage for individual procedures, the crossmatch to
transfusion ratio (CTR). This aims to reduce the number of excessive
crossmatched units of blood peroperative procedure.9,11,12
The MSBOS has been successfully implemented in the United
States demonstrating reduced wastage of crossmatched blood and
ﬁnancial savings.13e16 It was ﬁrst implemented in the United
Kingdom in 1990 and studies have mirrored those in the US and
found signiﬁcant savings.9,11e13
It has been the practice of our vascular department to cross-
match two units for EVAR on the basis of an expected but variable
quantity of blood loss and with the potential concern of signiﬁcant
haemorrhage. An MSBOS for EVAR has not been recommended and
this study aims to deﬁne this standard.Material and Methods
A retrospective analysis was carried out of every EVAR procedure
carried out at Frimley Park NHS FoundationTrust (FPH) fromOctober
2001 to December 2010. Patients were identiﬁed from a prospective
EVARdatabase and transfusion information collated from the current
hospital pathology database (Clinisys WinPath) and a previous
version (iSOFTTPath).Data recordednumberofunits crossmatched,
used and returned, including the use of fresh frozen plasma and
platelets. Haemoglobin concentration was recorded preoperatively
and on the ﬁrst postoperative day. Patients with evidence of cardio-
vascular compromise had haemoglobin concentration assessed
during the procedure and in the immediate postoperative period.
Operative blood loss, complications and reasons for transfusion
were recorded from the operation record and hospital notes. In our
transfusion department the cost of a group and save (or type and
screen/group and screen) sample is £3.48 (V3.96). To crossmatch
and transfuse one unit of red blood cells costs £137.22 (V158.94).
The combined data were analysed to produce basic descriptive
statistics and a CTR. The CTR is calculated by dividing the number of
units crossmatched by the number of units transfused of all
procedures in the study.Figure 1. Crossmatching trendUnfortunately open aneurysm repairs were not directly studied
or statistically compared to EVAR procedures. A local audit carried
out on transfusion requirements of open aneurysm repairs in 2010
is described below for crude descriptive comparison.Results
A total of 219 EVAR procedures were performed in the nine-year
study period. There were 203 elective procedures and 16 emer-
gency procedures. The 16 emergency procedures were either
symptomatic or ruptured aneurysms and were excluded from the
study.
There has been an increase in number of EVAR procedures
performed each year since the program began in 2001. Approxi-
mately in excess of sixty elective procedures are currently per-
formed each year. Fig. 1 demonstrates that the majority of patients
have crossmatched 2 units in line with departmental policy.
Mean operative blood loss was 288 ml with a median of 200 ml,
range 50mle8400ml. Themajority of blood loss was during sheath
and guidewire exchanges in the exposed iliac vessels. There was
a mean preoperative haemoglobin of 13.3 g/dL (standard deviation
1.7) and a mean postoperative drop of 1.7 g/dL (standard deviation
1.2). A total of twelve patients (6%) required red blood cell trans-
fusion. The indication for each case is summarised in Table 1.
Two (1%) patients required immediate peroperative transfusion
for iatrogenic iliac ruptures and had conversion to open operations.
A further patient developed a large groin haematoma requiring
operative evacuation and massive transfusion, deﬁned as
a replacement of the patients’ whole circulating volume. Six
patients received transfusions postoperatively for a reduction in
haemoglobin to less than 8 g/dL. Three patients were transfused
despite having haemoglobin concentrations greater than 8 g/dL.
Additional blood products were used for three patients with large
volume haemorrhage to reduce the risk of coagulopathy (Table 1).
The CTR of all elective EVAR procedures is 11.1 (for every red
blood cell unit transfused, 11.1 units were crossmatched and
unused).Discussion
Although the ideal CTR for any surgical procedure would be 1,
this is both unattainable and unsafe. It has been recommended that
a CTR of 2e3 is acceptable which would result in 30e50% ofs over the study period.
Table 1
Indication for transfusion.




76 _ 7.9 500 ml 1 Nil Hb <8 g/dL
82 _ 7.5 500 ml 2 Nil Hb <8 g/dL
76 _ 7.7 750 ml 2 Nil Hb <8 g/dL
73 _ 7.9 650 ml 2 Nil Hb <8 g/dL
87 _ 7.7 150 ml 2 Nil Hb <8 g/dL
75 _ 7.7 300 ml 2 Nil Hb <8 g/dL
65 _ 8.2 800 ml 2 Nil Signiﬁcant blood loss
87 _ 8.1 300 ml 2 Nil Developed Hypotension and AF
73 _ 8.5 1400 ml 2 Nil Signiﬁcant blood loss, transfused in recovery
Major
79 _ e >3000 ml 8 3 units fresh
frozen plasma
Ruptured Iliac Artery, required open procedure
and iliac patchplasty
84 \ e >3000 ml 9 11 units fresh frozen
plasma 2 units platelets
Signiﬁcant blood loss, developed right groin
haematoma requiring a return to theatre
and development of DIC
84 _ e >8000 ml 28 12 units fresh frozen
plasma 4 units platelets
Ruptured Iliac Artery, required open procedure,
iliac tie off and bypass. Developed DIC postoperatively
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than 4, the likelihood of transfusion for that particular procedure is
low enough to require a group and save only. Given the CTR for this
study is 11.1, there is a very low risk for transfusion and a group and
save should be the recommended MSBOS for elective EVAR.10,11
It is departmental policy to transfuse patients if the haemoglo-
bin falls to less than 8 g/dL. There is clear evidence that transfusing
anaemic patients reduces the risk of mortality, especially in
patients with cardiac disease.17,18 The haemoglobin threshold for
transfusion in these patients is unclear and a restrictive strategy
may result in optimal survival.19,20 In this study a patient with
a haemoglobin >8 g/dL was transfused after developing atrial
ﬁbrillation. There were no other adverse cardiac outcomes in our
series and further research is required to delineate optimal trans-
fusion thresholds.
Subgroups of patients exist for whom crossmatched blood will
be required routinely. For example, those with antibodies found on
group and save screen will require blood to be available in case of
unanticipated major blood loss and patients with known clotting
disorders may require speciﬁc haematological preparations to be
administered before a procedure is performed.
Predicting the risk of transfusion for patients undergoing EVAR
based on ‘difﬁcult’ anatomy is unreliable. Anatomical variability has
been classiﬁed into mild, moderate and severe risk stratiﬁcation
groups in an attempt to predict risk of complications.21 A multi-
variate analysis on our retrospective data would potentially eval-
uate risk factors of massive transfusion, but this is a relatively small
dataset and such an analysis is unlikely to be reliable.
All EVAR procedures in the study were performed through
bilateral groin incisions, the femoral arteries being closed primarily.
Percutaneous approaches are now common and a recent review
has shown similar or slightly lower rates of transfusion compared
with open femoral approaches. There were also similar rates of
blood loss and postoperative morbidity.8,22 In the future, it is likely
that our unit will selectively use percutaneous techniques to access
the femoral artery and it is our intention to continue to audit blood
loss and transfusion rates.
Each hospital is required to have an emergency transfusion
protocol to manage massive blood loss. These protocols stipulate
that O negative blood must be immediately available and group
speciﬁc blood within 10 min. A full crossmatch should be available
within 15 min. It is important to note that, in this situation, group
speciﬁc blood confers no additional safety beneﬁt to O negative
blood except to preserve the quantities of O negative supplies. Onegative blood is always screened for the most signiﬁcant non-ABO
antibodies.13 Though not observed at our trust, O positive blood is
a suitable blood product for use in emergency situations.23
The anaesthetist and surgeon must weigh up the beneﬁts of
using non-crossmatched blood depending on the cardiovascular
status of the patient, although haemorrhage control is the main
priority. A cell salvage device may be employed in endovascular or
open procedures to provide autologous transfusion and is partic-
ularly useful in emergency setting.24 The decision to wait for
crossmatched blood is a crucial one and may place the patient at
risk but a protocol driven co-ordinated approach from all members
of the operating team will result in improved outcomes.25
The MSBOS tool was reported two decades ago and many
authors have demonstrated its effectiveness. Despite this, its
widespread use has not been implemented. For a recommendation
to become the MSBOS for any institution, an agreement between
the surgeon, anaesthetist and haematologist is required. The key to
implementing these strategies lies in the education of the theatre
and management teams regarding the MSBOS tool, data collection
and emergency transfusion protocols.
The proportion of patients requiring transfusion should be used
in conjunction with MSBOS in determining optimal crossmatching
protocols. Patients undergoing open AAA repair usually have an
MSBOS of four to six units but frequently less than half the cross-
matched units are transfused.9,12 Local audit data of 33 open elec-
tive AAA repairs in 2010, give a CTR of 10.5 but an intraoperative
transfusion rate of 33%. It is evident that the majority of vascular
units use surrogate protocols for EVAR derived from protocols used
for open repair, which, in the authors’ opinion, is an unnecessarily
defensive practice.
This study has highlighted the inefﬁcient and costly practice of
crossmatching blood during elective EVAR. From January to
December 2010, 6.6% of red cell units were discarded. Reviewing
our 2010 data, a potential ﬁnancial loss of £21,258 (V24,640) was
reduced to £1403 (V1626) with efﬁcient red cell recycling. The true
impact of wasted red cell units, however, includes not only the
ﬁnancial loss but the drain on resources through wasted processing
and manpower.
As the number and proportion of EVAR procedures increases
there is likely to be a decline in open aneurysm repair. Despite the
use of autotransfusion, our 2010 data showed a 33% transfusion rate
for elective open aneurysm procedures and 180 red cell units were
returned to the transfusion department. Approximately 6.6% of
these units were discarded resulting in a ﬁnancial loss of £1589
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are unlikely to change due to the unpredictable nature of trans-
fusion. Performing more EVARs is likely to result in a modest
absolute reduction in direct transfusion costs, but considerable
savings in terms of manpower and efﬁciency.
We are currently evaluating transfusion ratios of other major
vascular procedures and plan to extend this study to evaluate the
MSBOS of all major surgical procedures within the general surgical
directorate. Applying the above principles across other surgical
specialities, may lead to signiﬁcant ﬁnancial savings, improve efﬁ-
ciency and reduce wastage.
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